STOP_Whining Posted - 1 week ago

@FE123 $TRIL had the same pattern just before getting bought out. Patience will pay off for investors in $IOVA

SpringGunner Posted - 2 weeks ago

$GOEV This reminds me of $TRIL from a couple of years ago. Just when they started getting results with their molecules article after article came out about their cash burn rate and them not making money. The message boards would fill up and go ballistic with negative comments every time they would give an investor update with good news and progress. YouTube had video after video saying there was no catalyst to make it move up and to get out. They ran it down to a little over $4 before Pfizer bought it out for $18.50. I got fat on that one. 10,000 shares at $5.23 Last year I remember an article on Canoo saying to sell and get out because the market for three wheeled vehicles was already saturated. Honestly, how low is the bar for these guys to get a writing job.

BrandNewLambo Posted - 03/26/24

$TRIL Been looking for the next Jan Svarka. Thinking David Lazar may be worth keeping an eye on at $OPGN

FE123 Posted - 03/26/24

$ALT Has to be PFE for the Buyout!! They did same Manipulation with $TRIL

Koepkesd Posted - 03/22/24

@iBoughtTheWrongTicker THe $TRIL ticker doesn’t exist anymore. What happened with it? Epic rally?

Gunnar1 Posted - 03/21/24

@Steve_TheBull_Rogers Okay, here's some anecdotal evidence: I remember that around 2019/2020 it was also the case with $TRIL that IR never answered (ask @rockytrades). Then came the BO by Pfizer. Meanwhile at $TCON, the CEO himself responded a few times when Rocky mailed him. But all in all, it was a absolute shitshow. So the lesson is: never trust a company that reply to your emails. 😉

iBoughtTheWrongTicker Posted - 4 weeks ago

$ATOS if newbies come and click in the 3/6/12 mo chart and think ahhhh it’s already reached its potential it’s up 125% in a year - uhhh dudes this shit was up on less news in the $9’s, the market cap is still a measly $160M. When I had $TRIL at a dollar, and it ran to $7 people thought the same, and after P2 readout data, Pfizer scooped them up for $18.50. This is biopharm and it’s the riskiest segment but also the one with the most payoff. Multiples are expected, not your S&P average type gains. We are literally just getting started. And catalysts are RIGHT AROUND THE CORNER.

Metal_Health Posted - 1 month ago

@outNabout $BREA that 57 million volume gap will be filled and much more. This stock reminds me of $TRIL I started buying the hell out of that when it dropped from $4 to $1.75. $PFE acquired them in 2017 for $18.50/share.

iBoughtTheWrongTicker Posted - 1 month ago

@Lemonz32 @dcajic2 I’ve posted this before but $TRIL was picked up on positive data at P2…Pfizer didn’t seem to think twice about it. I held on all the way through the buyout at $18.50. My first share was picked up under $2…

iBoughtTheWrongTicker Posted - 1 month ago

@chrundrel lesson learned if you like what you’re seeing and you don’t need the money immediately and you monitor it daily why even have a SL…bios fluctuate to a much wider degree as other stocks but with great risk does occasionally come great reward. Held $TRIL straight through P2 data and buyout at $18.5 another oncology drug

F14TomcatGuy Posted - 1 month ago

$GNS some of the companies I invested in had massive drops before they mooned. $TRIL $PR (CDEV). The market will drop good stocks on purpose to make you sell so the "ones in the know" can buy more shares lower. They will drag it out for a while to get most investors to sell. Then boom news hits and it rockets. Now you and others will chase the stock driving up the price and then they will sell with a massive profit.

Longroader Posted - 2 months ago

$SGMO Fabry sale, Hem A update, partnership.....not selling at $1 if its going to $10. $TRIL 77x returns

ianchris Posted - 2 months ago

@OldFngGuy hahaha I do some pennies on the side for fun when 90% of my accounts are in the broad market. I made $500k on $TRIL if you read back that far on my account. It came down to $0.25 at the min and then sold to Pfizer for $17.50/share. Owned 100k shares at one point.

boilerrm04 Posted - 01/27/24

@Yarrow ah yes. I had fomo on $alxo remember that one hitting $120 when $tril went for $18! $fixx was on my list to buy after $lptx bc of the $pfe investment but that didnt seem to pan out. Yes lots of companies with great science, no investor love, trading at or below cash and they all just need more data!!!

boilerrm04 Posted - 01/25/24

@lomaglnc thanks will do! I did ride the $TRIL roller coaster, from $2 to $22 then back to $5 then buyout at $18.44. Even if this did exactly that, I would still be down$40 per share.

boilerrm04 Posted - 01/25/24

@zbo @beforethedeluge Yes its going to take a long time to recoup this! All my $TRIL was in $LPTX.

beforethedeluge Posted - 01/25/24

@kamikaze_andy Don't know if you followed $TRIL but if you had taken the action when it was just dribbling away, you would have lost out on the buyout. It wasn't looking very good prior to the buyout. I know that's just one example, but many times inaction is the best action.

EddieH2020 Posted - 01/22/24

$PDSB Maybe Frank realized we are the new $TRIL and he is letting everyone retire 🤣

frontiere Posted - 01/20/24

$BNOX a + sign for me is that Spyros and his team was v likely poached / convinced to join from $VIGL , not fired / other negative. Resigned 11 Dec’22 effective 4 Jan’23. Signed w BNOX 16 Dec’22 effective 5 Jan’23. Base salary up 25% from 400k to $500k+, plus 50% bonus, plus 27m stock options (Aus? So ≈150k ADS??) struck at effective $3+ ADS (5day trailing pre 21 Feb’23…very approx). Can Spyros achieve what Jan Skvarka did with $TRIL Trillium? 🤔😁 Dream, dream, dream.

FE123 Posted - 2 months ago

$ALT PFE Needs More Shares!! They did the same to $TRIL before Buyout!

SDB405 Posted - 3 months ago

@Wkdwalker @jascar It feels like the same song and dance as $TRIL . This is just a part of the game, I'm going to keep piling on the shares knowing it may take a year or two. When nothing makes sense I begin to understand it’s by design. I don’t think this management team is that incompetent.

FE123 Posted - 3 months ago

$ALT $PFE did the same thing with $TRIL, Manipulated and Shorted until they announced Buyout! $ALT Expecting a buyout around $50

BoomerS Posted - 3 months ago

@allgoodstill @tomRussell80 @Sleepwhndead I’ve placed my bet that this will be better than $TRIL. Guess we will have to wait and see.

NeverShort Posted - 3 months ago

@Cholder123 Oh well that's disappointing... A quick history check shows that $TRIL only went 3x up from about $6 to $18.44 acquisition price I am hoping $ENLV will do at-least a 10x jump to $30 or so

ScorpioRising Posted - 3 months ago

$AUPH Best possibility: PG and board want to sell. But since it hasn't sold by now, 3 years later, that means no one wants to buy, or not anywhere near a price reasonable to PG/board's acceptance. Worst possibility: PG and board don't want to sell, and would rather merge or acquire another company and grind harder down the GIA road. Shareholders continue to get screwed either way. And I think ousting PG and other board members would tank the stock in the short run, but maybe eventually lead to shareholder relief in the long run (I think it took $TRIL 1 year or more to sell after change of CEO). PG, please do something with this "strategic review" and pull the band-aid off if that's what you are going to do (GIA).

boilerrm04 Posted - 12/22/23

@areder @beforethedeluge @Apr4609 yea i remember when that one blew up with $TRIL and $FTSV. I owned both. $AXSM got up to $120 p/s and was touted as more advanced than $TRIL at the time

YourfrenPepe420 Posted - 4 months ago

@SelectiveTrader I remember $TRIL ran from .50 to $16 on this type of fda approval. Company got bought out by $PFE

Looking4Bargain Posted - 4 months ago

$ATOS when this pays out it will be money maker. Seen this flirt with $20 a share before and just the fact that Quay had done this before and has balance sheet for trials is right track for this company. I think this will get bought out eventually similar to $TRIL. Just needs long term investment and patience.

soll Posted - 4 months ago

The quality of the MANAGEMENT, BOARD OF DIRECTORS, SCIENTIFIC ADVISORY BOARD is truly remarkable for a newer company of this size. Harvard, MIT, Stanford, ETC. Amgen partnership (Crohn’s disease) earlier this year. 70 million shares traded in two days. Recent ASH results. Pipeline Boris Peaker (analyst for TD Cowen) is why I first started watching $TCRX two plus years ago. Boris liked $TRIL which I owned 88,000 shares of when their buyout was announced a couple years back.

boilerrm04 Posted - 4 months ago

@Bukslayer @TrimT @Apr4609 @Olleke in 2021 they raised like $90 mm with an ATM at $2.85 or $28.50 split adjusted. The market cap was around $370mm. Now withe flame dilution, $370 mm is $12.30 per share @30 million o/s. So the company needs to be worth $855 million just for those shareholders to break even. $28.50 @ 30 million o/s. Kinda sad to go through all this riggamaroo roller coaster ride for just a double. The newbies will make out and call this a grandslam but for the original shareholders it will be just a base hit making the risk/reward not as enticing. We need $5 billion like those $FTSV and $TRIL deals to all get excited that would put everyone at a significant premium. $5 billion would be $166 per share or $16.60 pre split.